title: Diagnostic and therapeutic challenges.
authors.forename: Xuan T
authors.initials: XT
authors.lastname: Le-Nguyen
authors.forename: Thomas K M
authors.initials: TK
authors.lastname: Lee
authors.forename: Diana V
authors.initials: DV
authors.lastname: Do
authors.forename: Yasir J
authors.initials: YJ
authors.lastname: Sepah
authors.forename: Quan Dong
authors.initials: QD
authors.lastname: Nguyen
authors.forename: Narsing A
authors.initials: NA
authors.lastname: Rao
authors.forename: Daniel V
authors.initials: DV
authors.lastname: Vasconcelos-Santos
authors.forename: Debra A
authors.initials: DA
authors.lastname: Goldstein
mesh_terms: D000328:Adult; D000638:Amiodarone / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000150:complications* / Q000188:drug therapy; D003937:Diagnosis, Differential; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009898:Optic Disk / Q000187:drug effects*; D010211:Papilledema / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000150:complications* / Q000188:drug therapy; D014665:Vasodilator Agents / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D014792:Visual Acuity / Q000502:physiology; D014794:Visual Fields
chemical_list: D005938:Glucocorticoids; D014665:Vasodilator Agents; D000638:Amiodarone; D011241:Prednisone; D008727:Methotrexate